Stephanie Moquin

3.7k total citations
17 papers, 441 citations indexed

About

Stephanie Moquin is a scholar working on Infectious Diseases, Molecular Biology and Virology. According to data from OpenAlex, Stephanie Moquin has authored 17 papers receiving a total of 441 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Infectious Diseases, 5 papers in Molecular Biology and 5 papers in Virology. Recurrent topics in Stephanie Moquin's work include SARS-CoV-2 and COVID-19 Research (7 papers), HIV Research and Treatment (5 papers) and Computational Drug Discovery Methods (4 papers). Stephanie Moquin is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (7 papers), HIV Research and Treatment (5 papers) and Computational Drug Discovery Methods (4 papers). Stephanie Moquin collaborates with scholars based in United States, Switzerland and Germany. Stephanie Moquin's co-authors include Celia A. Schiffer, Dustin Dovala, Julia M. Flynn, Daniel N. Bolon, Neşe Kurt Yılmaz, JJ L. Miranda, John R. Mascola, Tongqing Zhou, Peter D. Kwong and Sarah N. Zvornicanin and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Stephanie Moquin

15 papers receiving 438 citations

Peers

Stephanie Moquin

VIROL

IMMUN

CTM

Manon Eckhardt United States

Zenda Woodman South Africa

Chinh Tran-To Su Singapore

Kosi Gramatikoff United States

Fangzhu Zhao United States

Marie-Josée Massariol Canada

Jean‐Louis Pérignon France

Heidi Jonckheere Belgium

Julie Q. Hang United States

Manon Eckhardt United States

Stephanie Moquin

99 ×0.6

267 ×1.6

143 ×1.1

VIROL

104 ×1.1

IMMUN

40 ×0.5

CTM

Citations per year, relative to Stephanie Moquin Stephanie Moquin (= 1×) peers Manon Eckhardt

Countries citing papers authored by Stephanie Moquin

Since Specialization

Citations

This map shows the geographic impact of Stephanie Moquin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephanie Moquin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephanie Moquin more than expected).

Fields of papers citing papers by Stephanie Moquin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephanie Moquin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephanie Moquin. The network helps show where Stephanie Moquin may publish in the future.

Co-authorship network of co-authors of Stephanie Moquin

This figure shows the co-authorship network connecting the top 25 collaborators of Stephanie Moquin. A scholar is included among the top collaborators of Stephanie Moquin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephanie Moquin. Stephanie Moquin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Sun, Long, Jing Zou, Yanping Hu, et al.. (2025). Mechanistic insights into dengue virus inhibition by a clinical trial compound NITD-688. Proceedings of the National Academy of Sciences. 122(13). e2426922122–e2426922122. 1 indexed citations

Zvornicanin, Sarah N., Ala M. Shaqra, Julia M. Flynn, et al.. (2025). Molecular mechanisms of drug resistance and compensation in SARS-CoV-2 main protease: the interplay between E166 and L50. mBio. 16(5). e0406824–e0406824. 2 indexed citations

Flynn, Julia M., Sarah N. Zvornicanin, Ala M. Shaqra, et al.. (2024). Contributions of Hyperactive Mutations in M^pro from SARS-CoV-2 to Drug Resistance. ACS Infectious Diseases. 10(4). 1174–1184. 9 indexed citations

Mugisha, Christian Shema, Vorada Chuenchob, Stephanie Moquin, et al.. (2024). Rapid-response RNA-fluorescence in situ hybridization (FISH) assay platform for coronavirus antiviral high-throughput screening. SLAS DISCOVERY. 29(8). 100189–100189.

Zvornicanin, Sarah N., Ala M. Shaqra, Qiu Yu J. Huang, et al.. (2023). Crystal Structures of Inhibitor-Bound Main Protease from Delta- and Gamma-Coronaviruses. Viruses. 15(3). 781–781. 5 indexed citations

Flynn, Julia M., Qiu Yu J. Huang, Sarah N. Zvornicanin, et al.. (2023). Systematic Analyses of the Resistance Potential of Drugs Targeting SARS-CoV-2 Main Protease. ACS Infectious Diseases. 9(7). 1372–1386. 17 indexed citations

Flynn, Julia M., Neha S. Samant, David T. Barkan, et al.. (2022). Comprehensive fitness landscape of SARS-CoV-2 Mpro reveals insights into viral resistance mechanisms. eLife. 11. 59 indexed citations

Shaqra, Ala M., Sarah N. Zvornicanin, Qiu Yu J. Huang, et al.. (2022). Defining the substrate envelope of SARS-CoV-2 main protease to predict and avoid drug resistance. Nature Communications. 13(1). 3556–3556. 73 indexed citations

Moquin, Stephanie, Sean Thomas, Sean Whalen, et al.. (2017). The Epstein-Barr Virus Episome Maneuvers between Nuclear Chromatin Compartments during Reactivation. Journal of Virology. 92(3). 46 indexed citations

10.

Moquin, Stephanie, et al.. (2017). Bromodomain and extraterminal inhibitors block the Epstein-Barr virus lytic cycle at two distinct steps. Journal of Biological Chemistry. 292(32). 13284–13295. 28 indexed citations

11.

Moquin, Stephanie, Kayla Martin, Shane McDevitt, et al.. (2017). PARP1 restricts Epstein Barr Virus lytic reactivation by binding the BZLF1 promoter. Virology. 507. 220–230. 35 indexed citations

12.

Gorman, Jason, Michael Joyce, Tongqing Zhou, et al.. (2016). Somatic Hypermutation-Induced Changes in the Structure and Dynamics of HIV-1 Broadly Neutralizing Antibodies. Structure. 24(8). 1346–1357. 27 indexed citations

13.

Acharya, Priyamvada, Tongqing Zhou, Cinque Soto, et al.. (2014). CD4-binding-Site Recognition by VH1-46 Germline-derived HIV-1 Neutralizers. AIDS Research and Human Retroviruses. 30(S1). A120–A121. 1 indexed citations

14.

Joyce, Michael, Masaru Kanekiyo, Ling Xu, et al.. (2012). Outer Domain of HIV-1 gp120: Antigenic Optimization, Structural Malleability, and Crystal Structure with Antibody VRC-PG04. Journal of Virology. 87(4). 2294–2306. 30 indexed citations

15.

Falkowska, Emilia, Alejandra Ramos, Yu Feng, et al.. (2012). PGV04, an HIV-1 gp120 CD4 Binding Site Antibody, Is Broad and Potent in Neutralization but Does Not Induce Conformational Changes Characteristic of CD4. Journal of Virology. 86(8). 4394–4403. 93 indexed citations

16.

Liberatore, Katie L., Justine R. Garcia, Ingo Burghardt, et al.. (2012). Symbiodinium diversity in the soft coral Heteroxenia sp. and its nudibranch predator Phyllodesmium lizardensis. Coral Reefs. 31(3). 895–905. 15 indexed citations

17.

Zhou, Tongqing, Stephanie Moquin, Rebecca M. Lynch, et al.. (2012). Structural definition for a new modality of broad and potent antibody neutralization at the CD4-binding site on HIV-1 gp120. Retrovirology. 9(S2).

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact